Last year, Taylor Knopf, a health care journalist at North Carolina Health News, spent more than a week out of a vacation to report on how France and Switzerland have been able to do what the health care system in the United States has so far failed to do: stem the tide of opioid-related deaths.
Every day, stories about the U.S. opioid epidemic appear in daily newsfeeds, and rightly so: they are responsible for two out of every three drug overdoses in the country.
But there’s another drug not included in the usual drug overdose stats which kills almost twice as many people a year as opioids — alcohol. And yet, a casual perusal of the daily headlines usually turns up as many fun or fluff stories about alcohol as ones that suggest the risks and harms of drinking. Continue reading
The Federal Trade Commission and State of New York late last month filed a lawsuit against Martin Shkreli, charging that Shkreli and Vyera Pharmaceuticals raised the price of the life-saving drug Daraprim by more than 4,000% and worked to corner the market for such drugs.
“The joint action accused Shkreli and Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, of scheming to ‘illegally’ prevent would-be generic competitors from selling a version of Daraprim,” as Stat’s Ed Silverman reported on Jan. 27. After acquiring the drug in 2015, Shkreli, dubbed the “Pharma Bro,” and Turing raised the list price of the medication from $17.50 per tablet to $750, he added. Continue reading
In her book, “Bottle of Lies: The Inside Story of the Generic Drug Boom,” Eban reveals how generic drug makers not only help ensure that some of the worst quality drugs enter the least regulated markets but also take extreme measures to avoid regulatory scrutiny. Harper Collins/Ecco’s Hardcover division published the book on May 14. Continue reading
A panel of experts in geriatric care has identified nearly 100 medications that should be avoided or used with caution among the older population in the latest update to the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
The recommendations by the American Geriatrics Society are widely used by clinicians, educators, researchers, health care administrators and regulators to ensure medications are appropriately prescribed. Continue reading
In one study, Greg Rhee, Ph.D., an adjunct assistant professor in the University of Minnesota College of Pharmacy, examined prescribing trends in outpatient settings of opioids and benzodiazepines. His analysis found that between 2006-07 and 2014-15, the prescription rates of benzodiazepine drugs such as Xanax and Halcion increased from 4.8 percent to 6.2 percent; the rate of prescription opioids alone increased from 5.9 percent to 10 percent, and the co-prescribing rate of both benzodiazepines and opioids increased over time from 1.1 percent to 2.7 percent, respectively. Continue reading